Calliditas Therapeutics AB
Health Care · Biologics & Biosimilars

Calliditas Therapeutics AB: Risk & public record

Calliditas Therapeutics AB: 33 research papers in five years.

Data updated Nov 20, 2026 · Back to the company report

What the registers and the postings say about this employer.

Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Public record

Calliditas Therapeutics AB: 33 research papers in five years.

Research outputpapers its people wrote, per OpenAlex
33papers in five years
1.1kcitations
Renal Diseases and Glomerulopathies
Medicine
36 papers
Chronic Kidney Disease and Diabetes
Medicine
34 papers
Renal Transplantation Outcomes and Treatments
Medicine
30 papers
Vasculitis and related conditions
Medicine
6 papers
Cancer Immunotherapy and Biomarkers
Medicine
3 papers
Each line links its register: the agency's page, the EU Transparency Register, the FEC, the USPTO, CourtListener.